BioCryst to acquire Astria Therapeutics for $920 million
Tweet Send to a Friend
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) announced it will acquire Astria Therapeutics Inc. (NASDAQ: ATXS) for $13.00 per share in a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
